Close Menu

Royal Institute of Technology

This is part one of a two-part interview. Part two is available here.

In a proof-of-concept study published last week in PLoS One, the scientists applied their strategy to analyze a single exon in nearly 5,000 samples with 122 tags using the 454 GS FLX sequencing platform.

Researchers involved in the Human Protein Atlas project announced that they are halfway through creating a resource that will contain data on all known human proteins.

With the release, the Protein Atlas project is now halfway to its goal of characterizing 20,000 human proteins, which it expects to reach sometime in 2015, said program founder and director Mathias Uhlen.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.